Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 15:13:1303249.
doi: 10.3389/fonc.2023.1303249. eCollection 2023.

Rapid progression from complete molar pregnancy to post-molar gestational trophoblastic neoplasia: a rare case report and literature review

Affiliations
Case Reports

Rapid progression from complete molar pregnancy to post-molar gestational trophoblastic neoplasia: a rare case report and literature review

Jing Qian et al. Front Oncol. .

Abstract

Background: Post-molar gestational trophoblastic neoplasia (pGTN) develops in about 15% to 20% of complete hydatidiform mole (CMH). Commonly, pGTN is diagnosed based on hCG monitoring following the molar evacuation. To date, no detailed information is available on how fast can pGTN develop from CHM. However, the concurrence of CHM and pGTN is extremely rare.

Case presentation: A 29-year-old woman presented to the gynecology department with irregular vaginal bleeding and an elevated hCG serum level. Both ultrasound and MRI showed heterogeneous mass in uterine cavity and myometrium. Suction evacuation was performed and histologic examination of the evacuated specimen confirmed complete hydatidiform mole. Repeated ultrasound showed significant enlargement of the myometrium mass one week after the evacuation. pGTN with prognostic score of 4 was then diagnosed and multi-agent chemotherapy regimen implemented with a good prognosis.

Conclusion: In rare cases, CMH can rapidly progress into pGTN. Imaging in combination with hCG surveillance seems to play a vital role guiding timely diagnosis and treatment in the specific condition. Low-risk gestational trophoblastic neoplasia (GTN) should be managed stratified according to the individual situation.

Keywords: complete hydatidiform mole; gestational trophoblastic disease; gestational trophoblastic tumor; hydatidiform mole; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Gray-scale pelvic sonography displayed a mixed echogenic mass in the uterine cavity, partially invading the myometrium, with honeycomb like internal echoes. (B) Color Doppler showed that the mass was filled with abundant blood flow signals. (C) Spectrum of arteriovenous fistula was measured in pulsed-wave Doppler. (D) Pelvic MRI scan depicted heterogeneous mass in uterine cavity with hemorrhage, invading to the myometrium.
Figure 2
Figure 2
(A) Microscopic image of the evacuated mole tissues. Arrow points to moderate to severe trophoblast proliferation. (B) Immunohistochemical staining of the evacuated mole tissues identified a negative stain of p57.
Figure 3
Figure 3
(A) Gray-scale pelvic sonography showed a large honeycomb like mass within the uterine fundus, close to the serosa. (B) Pulsed-wave Doppler detected a high-speed, low-resistance arteriovenous fistula spectrum.

Similar articles

Cited by

References

    1. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet (2010) 376(9742):717–29. doi: 10.1016/S0140-6736(10)60280-2 - DOI - PubMed
    1. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. . Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw (2019) 17(11):1374–91. doi: 10.6004/jnccn.2019.0053 - DOI - PubMed
    1. Eiriksson L, Dean E, Sebastianelli A, Salvador S, Comeau R, Jang JH, et al. . Guideline no. 408: management of gestational trophoblastic diseases. J Obstet Gynaecol Can (2021) 43(1):91–105. doi: 10.1016/j.jogc.2020.03.001 - DOI - PubMed
    1. Silva A, Monteiro K, Sun SY, Borbely AU. Gestational trophoblastic neoplasia: Novelties and challenges. Placenta (2021) 116:38–42. doi: 10.1016/j.placenta.2021.02.013 - DOI - PubMed
    1. Hui P. Gestational trophoblastic tumors: A timely review of diagnostic pathology. Arch Pathol Lab Med (2019) 143(1):65–74. doi: 10.5858/arpa.2018-0234-RA - DOI - PubMed

Publication types

LinkOut - more resources